Doctor profile · Federal record
Dr. Mary Holthaus, PA
Medical Physician Assistant (CMS: Physician Assistant) · Student in an Organized Health Care Education/Training Program · Annapolis, MD
- NPI 1285296913
- Accepts Medicare
- 7 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
122 Defense Hwy Ste 210
Annapolis, MD 214017071
(410) 266-9694 - Additional location
-
130 Love Point RD Ste 107
Stevensville, MD 216662132
Credentials & registration
- NPI registered
- July 2019 — 7 yrs on file
- Profile last updated
- January 19, 2023
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State license (1)
- Maryland #C07349
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285296913. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
16,465
Distinct HCPCS
10
Medicare allowed
$180,545
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0585 |
Injection, onabotulinumtoxina, 1 unit | 15,600 | 34 | $6 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 251 | 176 | $158 | |
96160 |
Administration and interpretation of patient-focused health risk assessment | 154 | 131 | $2 | |
96136 |
Administration of psychological or neuropsychological test, first 30 minutes | 123 | 110 | $38 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 109 | 84 | $113 | |
64615 |
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 75 | 32 | $139 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 60 | 53 | $28 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 51 | 51 | $195 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 31 | 27 | $80 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 11 | 11 | $147 |
In context: peer comparison
Among 8 peers in Annapolis Medical Physician Assistant, average services per provider: 469. This provider delivers 35× the peer median.Open Payments
Industry payments received
All-time total
$192
Transactions
5
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 3 | $142.83 | |
| Mitsubishi Tanabe Pharma America, INC. | 1 | $26.61 | |
| Neurelis, INC. | 1 | $22.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
673
Patients
141
Total drug cost
$142,878
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Memantine Hcl | Generic | 149 | 44 | $7,311 |
| Donepezil Hcl | Generic | 139 | 49 | $2,388 |
| Gabapentin | Generic | 93 | 23 | $1,202 |
| Ubrelvy (Ubrogepant) | Brand | 54 | 12 | $68,992 |
| Sertraline Hcl | Generic | 44 | 13 | $506 |
| Emgality Pen (Galcanezumab-Gnlm) | Brand | 37 | 0 | $27,958 |
| Sumatriptan Succinate | Generic | 27 | 0 | $377 |
| Rivastigmine | Generic | 25 | 0 | $11,115 |
| Rizatriptan (Rizatriptan Benzoate) | Brand | 18 | 0 | $372 |
| Aimovig Autoinjector (Erenumab-Aooe) | Brand | 17 | 0 | $20,155 |
Hospital affiliations
Frequently asked questions
What is Dr. Mary Holthaus's medical specialty?
Dr. Mary Holthaus practices Medical Physician Assistant in Annapolis, MD.
Where does Dr. Mary Holthaus practice?
Dr. Mary Holthaus practices at 122 Defense Hwy Ste 210, Annapolis, MD 214017071. Office phone: 4102669694.
What is Dr. Mary Holthaus's NPI?
Dr. Mary Holthaus's National Provider Identifier (NPI) is 1285296913, issued by NPPES.
Does Dr. Mary Holthaus accept Medicare assignment?
Yes. Dr. Mary Holthaus accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mary Holthaus commonly perform?
Top Medicare-reported procedures in 2023: Injection, onabotulinumtoxina, 1 unit (HCPCS J0585); Established patient office or other outpatient visit (HCPCS 99215); Administration and interpretation of patient-focused health risk assessment (HCPCS 96160). Source: CMS Medicare Physician & Other Practitioners file.